Insights6 min read
Hyderabad is the epicenter of India’s FDA pressure
The Hyderabad corridor accounts for hundreds of drug inspections and a dense VAI cohort since FY2024 — plus a cluster of recent Warning Letters you can trace end-to-end.
If you want one geography that concentrates India’s FDA pressure, start with Hyderabad and the surrounding corridor — Sangareddy, Medchal, Patancheru, Pashamylaram, Bachupally, Jeedimetla.
Why the corridor matters
- Hyderabad: most-inspected drug city in India — 225 inspections all-time, 87 since FY2023
- Corridor (Hyderabad + surrounding nodes): 458 inspections across 164 distinct firms
- 114 inspections of 104 firms since FY2024 alone
- 68 corridor inspections since FY2024 ended VAI — the “warning shot” cohort
Recent drug-inspection volume by city
| City | FY23–26 inspections | All-time OAI rate |
|---|---|---|
| Hyderabad | 87 | 7.6% |
| Ahmedabad | 68 | 7.8% |
| Navi Mumbai | 45 | 15.4% |
| Bengaluru | 40 | 10.1% |
| Vadodara | 28 | 10.7% |
| Visakhapatnam | 23 | 6.7% |
| Sangareddy | 22 | 9.2% |
| Chennai | 20 | 9.5% |
| Vapi | (30 all-time) | 30.0% |
Fresh VAI names in the corridor (sample)
Selection of 16 of the 68 corridor VAIs since FY2024:
| Firm | Location | Inspection ended |
|---|---|---|
| Apitoria Pharma (Aurobindo group) | Pashamylaram / Sangareddy | Dec 2025 |
| Aizant Drug Research Solutions | Hyderabad | Nov 2025 |
| Vimta Labs | Hyderabad | Nov 2025 |
| Granules India | Sangareddy | Jun 2025 |
| Hetero Drugs | Gummadidala, Sangareddy | May 2025 |
| MSN Laboratories | Patancheru, Sangareddy | May 2025 |
| Neuland Laboratories (Unit II) | Sangareddy | May 2025 |
| Dr. Reddy’s (Unit II) | Jinnaram, Hyderabad | Nov 2024 |
| Biological E. | Medchal | Nov 2024 |
| Gland Pharma | Hyderabad | Jul 2024 |
Repeat OAI names also cluster here and nationally — Sun Halol, Eugia Sangareddy, Somerset Bengaluru, and others show up again and again across the longer history. 52% of India drug firms have been inspected more than once; the median historical gap (~2.7 years) is shrinking under unannounced-inspection posture.
The corridor is where inspection volume, VAI density, and recent Warning Letters line up on the same map — useful for prioritization, not for shaming any single plant.